JENNIFER LENZI: Open Payments
NPI 1194172684 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,660 in 76 payments from 15 companies in 2025. Trend: 2023 $219 · 2024 $1,167 · 2025 $1,660
Food & beverage: $1,581Education: $79
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $366 |
| GlaxoSmithKline, LLC. | 21 | $325 |
| Regeneron Healthcare Solutions, Inc. | 12 | $180 |
| Haemonetics Corporation | 1 | $159 |
| GENZYME CORPORATION | 9 | $138 |
| Verona Pharma, Inc. | 6 | $115 |
| Lilly USA, LLC | 4 | $98 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| Insmed, Inc. | 3 | $53 |
| Amgen Inc. | 2 | $38 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, TEG6S HEMOSTASIS SYSTEM, Ohtuvayre, ZEPBOUND, FASENRA, AIRSUPRA.
Industry payments across NJ — which companies pay providers there.
